Your Science Will Change the World

Our Programs will Help You Do It

SciCellerate Offers Three Programs
To Help Emerging Biotechs
Bring Their Science to the World

Discovery to IND

Bringing your drug target to the point where it's ready to be tested in humans is a complex and exciting step in the journey to bringing a new drug to the world.

SciCellerate's

Discovery to IND ("Investigational New Drug")

program helps scientific teams advance their ideas to the point where they are ready to be submitted to regulatory authorities for eventual human testing.

Our program also provides you with unprecedented access to sophisticated drug industry players who may want to explore partnerships, collaborations and other alliance structures with your company as you scale and grow.

Phase 1 to Phase 3

Congratulations! Your IND has been endorsed by regulatory authorities!

You've entered the stage where your molelcule is being tested in humans.

Now what?

SciCellerate's

Phase1 to Phase 3

program gives you access to an extensive network of biopharma industry veterans, who will coach you every step of the way to ensure your drug has the best chance of achieving clinical success and reaching the commercialization stage, where you will maximize the value of your science for the patients you will eventually serve, as well as your investors and your employees.

Filing, Launch & Lifecycle Management

Submitting your filing to regulatory authorities is a critical milestone along the way to achieving approval and commercial launch.

SciCellerate's Filing, Launch and Life Cycle program is designed to ensure you navigate post-clinical trial processes with confidence.

Our experts have launched drugs across numerous disease categories, MOA and delivery systems. They have the experience and the know-how to ensure that your regulatory dossiers are successfully submitted and your product launch plan gets executed according to plan.

Should larger pharmaceutical organizations express interest in your technology, Scilentia's experts will mentor you through the business processes that naturally follow.

The Scilentia Difference
Scilentia's 3-step learning process helps you craft your drug discovery, development and commercialization plans so that you are confident and ready
to meet with investors and large pharma partners.

(1) Scilentia's expert faculty members teach you the realities of the complex steps required to get a drug target shaped up and ready for an IND, a pharma partnership or your company's first drug launch. You will interact with top professionals who have successfully advanced candidates to the clinic and into the commercial space, and you will learn the realities of the process directly from them.

2) Case studies drawn from actual industry discovery, development and commercialization successes and failures form the framework for ongoing class discussion. You will work in small groups with individuals from other organizations within your cohort to test thinking, share best practices, and compare your decisions against those that were actually made by the teams responsible for the real-life drug.

(3) Finally, you'll work closely with your assigned Scilentia Global Partner and the experts who have led you through the program to craft an optimized strategy for your organization's drug candidate. This critical document is the foundational input to your pitch deck, your communications with investors and even your social media efforts.